By Alice Klein We’re not spending as much time in the office as we usually doEzra Bailey/Getty Images When office employees return to work, they may find that buildings with increased natural light help them to work better during the day and sleep better at night. We know that sunlight exposure is important for regulating…
By Michael Le Page Experts say planes should add air filters to help limit the spread of coronavirusCavan Images / Alamy Stock Photo Ventilation must be improved in buildings and aeroplanes to reduce the risk of covid-19 spreading via the air, according to recommendations from several organisations, including the European Union Aviation Safety Agency. However,…
Beginning Monday, dentists can begin resuming "routine oral and dental care" under new guidance from the Illinois Department of Public Health. "IDPH has carefully monitored the daily number of newly reported COVID-19 cases. If the trend continues as anticipated, certain models indicate there will likely be a decrease in the burden of COVID-19 illness in…
2016 analysis of various research papers from around the world found that around 16 percent of flu transmission takes place in the office.Other research shows that one of the best ways to reduce transmission in the workplace is to provide paid sick leave that encourages ill employees to stay home.ImageA common area at Mobify, a…
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.